Stock Code: 603605 | Stock Abbreviation : Proya |
Bond Code: 113634 | Bond Abbreviation: Proya convertible bond |
Proya Cosmetics Co., Ltd.The Third Quarter Report in 2022
Important Note:
The Board of Directors, Board of Supervisors, directors, supervisors and officers of the Companywarrant that the contents of the Quarterly Report are authentic, accurate and complete without anymisrepresentations, misleading statements or material omissions, and they will be jointly and severallyliable therefor.
The Chairman, the chief financial officer and the head of the accounting department warrant that thefinancial statements herein is authentic, accurate and complete.
Whether the third quarter financial statements have been audited.?Yes √No
I. Main Financial Data(I) Main Accounting Data and Financial Indicators
Unit: Yuan Currency: RMB
The Board of Directors and all directors of the Company warrant that the contentsherein are free from misrepresentations, misleading statements or material omissions, andthey will be jointly and severally liable for the authenticity, accuracy and completenessthereof.
Item
Item | The Reporting Period | YOY change in the Reporting Period (%) | From the beginning of the year to the end of the Reporting Period | YOY change in the period from the beginning of the year to the end of the Reporting Period (%) |
Operating income | 1,336,130,787.67 | 22.07 | 3,962,074,031.96 | 31.53 |
Net profit attributable to shareholders of the listed | 198,375,641.64 | 43.55 | 495,315,157.18 | 35.96 |
company | ||||
Net profit attributable to shareholders of the listed company after deducting non-recurring profit or loss | 196,100,724.25 | 44.07 | 476,998,142.78 | 33.84 |
Net cash flow from operating activities | N/A | N/A | 771,873,333.67 | 57.37 |
Basic earnings per share (RMB/share) | 0.71 | 2.90 | 1.76 | -3.30 |
Diluted earnings per share (RMB/share) | 0.70 | 1.45 | 1.74 | -3.87 |
Weighted average return on equity (%) | 6.59 | Up by 1.17 percentage points | 16.51 | Up by 2.01 percentage points |
End of the Reporting Period | End of prior year | Change at the end of the Reporting Period over the end of prior year (%) | ||
Total assets | 5,461,758,028.57 | 4,633,049,783.03 | 17.89 | |
Owner’s equity attributable to shareholders of the listed company | 3,178,288,666.18 | 2,876,975,835.98 | 10.47 |
Note: “The Reporting Period” shall refer to the 3-month period ended September 30, 2022, as follows.
(II) Items and Amounts of Non-recurring Profit or Loss
Unit: Yuan Currency: RMB
Item | Amount in the Reporting Period | Amount in the period from the beginning of the year to the end of the Reporting Period | Note |
Gains or losses from disposal of non-current assets | |||
Unauthorized examination and approval, or lack of official approval documents, or occasional tax revenue return and abatement | |||
Government grants recognized in profit or loss for the current period (excluding government grants that are closely | 3,140,446.53 | 23,580,544.90 |
related to the Company’s business operations and gained at a fixed amount or quantity according to national uniform standards) | |||
Capital occupation fees charged to the non-financial enterprises and included in profit or loss for the current period | |||
Gains when the investment cost of acquiring a subsidiary, an associate and a joint venture is less than the fair value of the identifiable net assets of the investee | |||
Gains or losses from exchange of non-monetary assets | |||
Gains or losses from entrusting others with investment or asset management | |||
Asset impairment provision made resulting from force majeure such as natural disasters | |||
Gains or losses from debt restructuring | |||
Enterprise restructuring fees, such as staffing expenses and integration fees | |||
Gains or losses that exceeds the fair value in transaction with unfair price | |||
Current net gains or losses of subsidiaries established by business combination involving enterprises under common control from the beginning of the period to the combination date |
Gains or losses on contingencies that have no relation with the normal operation of the Company | |||
Gains or losses from change in fair value by held-for-trading financial assets, derivative financial assets, held-for-trading financial liabilities and derivative financial liabilities, and investment income from disposal of held-for-trading financial assets, derivative financial assets, held-for-trading financial liabilities, derivative financial liabilities and other debt investments, excluding the effective hedging businesses related with normal operations of the Company | |||
Reversal of impairment provision of accounts receivable and contract assets that have undergone impairment test alone | |||
Gains or losses from outward entrusted loaning | |||
Gains or losses from changes in the fair values of investment properties that are subsequently measured using the fair value model | |||
Impact of a one-time adjustment on current profit and loss according to the requirements of tax and accounting laws and regulations | |||
Custody fees of entrusted operation | |||
Other non-operating income and expenses besides the above items | -66,506.02 | 214,968.49 |
Other items that conform to the definition of non-recurring profit or loss | |||
Less: Effect of income tax | 806,896.17 | 4,416,105.71 | |
Effect of minority equity (after tax) | -7,873.05 | 1,062,393.28 | |
Total | 2,274,917.39 | 18,317,014.40 |
Descriptions on classifying non-recurring profit and loss items defined in the ExplanatoryAnnouncement No. 1 for Public Company Information Disclosures - Non-recurring Profit and Loss asrecurring profit and loss items.?Applicable √N/A
(III) Changes in Main Accounting Data and Financial Indicators and Main Reasons
√Applicable ?N/A
Item | Change ratio (%) | Primary reasons |
Operating income (from the beginning of the year to the end of the Reporting Period) | 31.53 | Mainly due to: 1. the YOY increase in the online channel income; 2. the rapid growth of the Second-growth-curve brands. |
Net profit attributable to shareholders of the listed company (the Reporting Period) | 43.55 | Mainly due to: 1. the YOY increase in the online channel income; 2. the increase of gross profit margin and the YOY increase in gross profit, operating profit and total profit. |
Net profit attributable to shareholders of the listed company after deducting non-recurring profit or loss (the Reporting Period) | 44.07 | The specific reasons are the same as above. |
Net profit attributable to shareholders of the listed company (from the beginning of the year to the end of the Reporting Period) | 35.96 | Mainly due to: 1. the YOY increase in the online channel income; 2. (1) Ningbo Timage Cosmetics Co., Ltd. (a controlled subsidiary of the Company) turned losses into profits during the Reporting Period; (2) Shanghai Healthlong Biochemical Technology Co., Ltd. (a controlled subsidiary of the Company) has ceased to be included in the consolidated financial statements since May 2021. |
Net profit attributable to shareholders of the listed company after deducting non-recurring profit or loss (from the beginning of the year to the end of the Reporting Period) | 33.84 | The specific reasons are the same as above. |
Net cash flow from operating activities (from the beginning of the year to the end of the Reporting Period) | 57.37 | Mainly due to: the YOY increase in the operating income and the increase of cash inflows from operating activities. |
II. Shareholders Information(I) Total Number of Common Shareholders, Number of Preferred Shareholders with Voting Rights, andthe Shareholding of Top Ten Shareholders
Unit: share
Total number of common shareholders by the end of the Reporting Period | 13,764 | Total number of preferred shareholders with voting rights by the end of the Reporting Period (if any) | 0 | ||||
Shareholdings of top ten shareholders | |||||||
Name of shareholder | Nature of shareholder | Number of shares held | Shareholding ratio (%) | Number of restricted shares | Pledged, placed with mark, lock-up or not | ||
Share status | Number | ||||||
HOU Juncheng | Domestic natural person | 97,670,741 | 34.45 | 0 | None | ||
Hong Kong Securities Clearing Company Limited | Other | 65,496,052 | 23.10 | 0 | None | ||
FANG Yuyou | Domestic natural person | 49,639,480 | 17.51 | 0 | None | ||
China Construction Bank Co., Ltd. - Yinhua Fuyu Theme Hybrid Securities Investment Fund | Other | 5,900,165 | 2.08 | 0 | None | ||
China Construction Bank Co., Ltd. - CUAM Consumer Industry Hybrid Securities Investment Fund | Other | 2,600,058 | 0.92 | 0 | None | ||
Aberdeen Standard Investment Management (Asia) Co., Ltd. - Aberdeen Standard - China A-share Equity Fund | Other | 2,552,293 | 0.90 | 0 | None | ||
Industrial and Commercial Bank of China Limited - Jingshun Changcheng Emerging Growth Hybrid Securities Investment Fund | Other | 2,380,000 | 0.84 | 0 | None | ||
CAO Liangguo | Domestic natural person | 2,268,997 | 0.80 | 0 | None |
Industrial and Commercial Bank of China Limited - CUAM Consumption Upgrade Hybrid Securities Investment Fund | Other | 1,100,038 | 0.39 | 0 | None | ||||
XU Junqing | Domestic natural person | 926,239 | 0.33 | 0 | None | ||||
Shareholding of top ten unrestricted shareholders | |||||||||
Name of shareholder | Number of unrestricted outstanding shares held | Type and number of shares | |||||||
Type | Number | ||||||||
HOU Juncheng | 97,670,741 | RMB common stock | 97,670,741 | ||||||
Hong Kong Securities Clearing Company Limited | 65,496,052 | RMB common stock | 65,496,052 | ||||||
FANG Yuyou | 49,639,480 | RMB common stock | 49,639,480 | ||||||
China Construction Bank Co., Ltd. - Yinhua Fuyu Theme Hybrid Securities Investment Fund | 5,900,165 | RMB common stock | 5,900,165 | ||||||
China Construction Bank Co., Ltd. - CUAM Consumer Industry Hybrid Securities Investment Fund | 2,600,058 | RMB common stock | 2,600,058 | ||||||
Aberdeen Standard Investment Management (Asia) Co., Ltd. - Aberdeen Standard - China A-share Equity Fund | 2,552,293 | RMB common stock | 2,552,293 | ||||||
Industrial and Commercial Bank of China Limited - Jingshun Changcheng Emerging Growth Hybrid Securities Investment Fund | 2,380,000 | RMB common stock | 2,380,000 | ||||||
CAO Liangguo | 2,268,997 | RMB common stock | 2,268,997 | ||||||
Industrial and Commercial Bank of China Limited - CUAM Consumption Upgrade Hybrid Securities Investment Fund | 1,100,038 | RMB common stock | 1,100,038 | ||||||
XU Junqing | 926,239 | RMB common stock | 926,239 | ||||||
Description of the association relationship or concerted action of the above shareholders | FANG Yuyou is the younger brother of HOU Juncheng’s spouse FANG Aiqin, so HOU Juncheng and FANG Yuyou are related. | ||||||||
Description of the participation of the top 10 shareholders and the top 10 unrestricted shareholders in the margin trading and refinancing business (if any) | None |
III. Other RemindersOther important information about the Company’s business during the Reporting Period for theattentions of investors?Applicable √N/A
IV. Quarterly Financial Statements(I) Type of Audit Opinion?Applicable √N/A
(II) Financial Statements
Consolidated Balance SheetSeptember 30, 2022
Prepared by: Proya Cosmetics Co., Ltd.
Unit: Yuan Currency: RMB Audit Type: Unaudited
Item | September 30, 2022 | December 31, 2021 |
Current assets: | ||
Cash and cash equivalents | 2,894,581,365.15 | 2,391,048,249.81 |
Balances with clearing agencies | ||
Placements with banks and other financial institutions | ||
Held-for-trading financial assets | ||
Derivative financial assets | ||
Notes receivable | ||
Accounts receivable | 61,903,721.27 | 138,626,627.90 |
Receivable financing | 3,031,831.88 | 3,242,000.00 |
Prepayments | 174,958,003.94 | 58,406,647.11 |
Premiums receivable | ||
Amounts receivable under reinsurance contracts | ||
Reinsurer's share of insurance contract reserves | ||
Other receivables | 20,569,960.98 | 66,043,707.81 |
Including: Interest receivable | ||
Dividends receivable | ||
Financial assets purchased under resale agreements | ||
Inventories | 690,124,090.74 | 447,938,758.29 |
Contract assets | ||
Held-for-sale assets | ||
Non-current assets due within one year | ||
Other current assets | 36,682,817.91 | 53,534,962.39 |
Total current assets | 3,881,851,791.87 | 3,158,840,953.31 |
Non-current assets: | ||
Loans and advances to customers | ||
Debt investments | ||
Other debt investments | ||
Long-term receivables |
Long-term equity investments | 151,406,031.44 | 169,959,536.27 |
Other investments in equity instruments | 146,402,400.00 | 56,402,400.00 |
Other non-current financial assets | ||
Investment properties | 69,349,497.02 | 70,321,868.00 |
Fixed assets | 553,359,059.64 | 558,981,209.20 |
Construction in progress | 177,430,957.16 | 108,678,896.27 |
Bearer biological assets | ||
Oil and gas assets | ||
Right of use assets | ||
Intangible assets | 424,758,523.08 | 397,145,124.29 |
Development expenditure | ||
Goodwill | ||
Long-term prepaid expenses | 22,255,673.60 | 29,756,474.11 |
Deferred income tax assets | 30,463,707.85 | 38,796,018.02 |
Other non-current Assets | 4,480,386.91 | 44,167,303.56 |
Total non-current assets | 1,579,906,236.70 | 1,474,208,829.72 |
Total assets | 5,461,758,028.57 | 4,633,049,783.03 |
Current liabilities: | ||
Short-term borrowings | 200,251,506.85 | 200,251,506.85 |
Loans from the central bank | ||
Taking from banks and other financial institutions | ||
Held-for-trading financial liabilities | ||
Derivative financial liabilities | ||
Notes payable | 64,606,867.00 | 79,156,771.40 |
Accounts payable | 678,833,258.07 | 404,026,241.16 |
Receipts in advance | 527,929.95 | 173,769.85 |
Contract liabilities | 115,157,348.57 | 91,151,985.32 |
Financial assets sold under repurchase agreements | ||
Customer deposits and deposits from banks and other financial institutions | ||
Funds from securities trading agencies | ||
Funds from underwriting securities agencies | ||
Employee benefits payable | 117,186,385.92 | 78,649,049.72 |
Taxes payable | 109,722,579.78 | 99,893,176.97 |
Other payables | 227,670,691.33 | 62,162,153.55 |
Including: Interest payable | ||
Dividends payable | ||
Fees and commissions payable | ||
Amounts payable under reinsurance contracts | ||
Held-for-sale liabilities | ||
Non-current liabilities due within one year | ||
Other current liabilities | 11,562,619.94 | 9,521,415.32 |
Total current liabilities | 1,525,519,187.41 | 1,024,986,070.14 |
Non-current liabilities: | ||
Insurance contract reserves | ||
Long-term borrowings | ||
Bonds payable | 718,644,660.27 | 695,586,778.80 |
Including: Preferred stock | ||
Perpetual bonds | ||
Lease liabilities | ||
Long-term payables | ||
Long-term employee benefits payable | ||
Provisions | 8,456,756.79 | 10,812,084.88 |
Deferred income | 4,856,945.83 | 6,416,263.33 |
Deferred income tax liabilities | 7,523,121.46 | 8,408,158.81 |
Other non-current liabilities | ||
Total non-current liabilities | 739,481,484.35 | 721,223,285.82 |
Total liabilities | 2,265,000,671.76 | 1,746,209,355.96 |
Owner’s equity (or shareholders’ equity ): | ||
Paid-in capital (or share capital) | 283,519,194.00 | 201,009,966.00 |
Other equity instruments | 50,906,662.82 | 50,956,622.11 |
Including: Preferred stock | ||
Perpetual bonds | ||
Capital reserve | 890,391,200.83 | 834,272,205.66 |
Less: Treasury shares | 164,976,000.00 | 5,628,128.21 |
Other comprehensive income | -1,611,822.41 | -1,247,674.10 |
Special reserve | ||
Surplus reserve | 100,634,780.00 | 100,634,780.00 |
General risk reserve | ||
Retained profits | 2,019,424,650.94 | 1,696,978,064.52 |
Total owners’ equity (or shareholders’ equity) attributable to equity holders of the parent company | 3,178,288,666.18 | 2,876,975,835.98 |
Minority interests | 18,468,690.63 | 9,864,591.09 |
Total owners’ equity (or shareholders’ equity) | 3,196,757,356.81 | 2,886,840,427.07 |
Total liabilities and owners’ equity (shareholders’ equity) | 5,461,758,028.57 | 4,633,049,783.03 |
The chairman of the Company: HOU Juncheng | CFO of the Company: WANG Li | Head of Accounting Department: WANG Li |
Consolidated Income StatementJanuary to September, 2022
Prepared by: Proya Cosmetics Co., Ltd.
Unit: Yuan Currency: RMB Audit Type: Unaudited
Item | First three quarters of 2022 (Jan. to Sep.) | First three quarters of 2021 (Jan. to Sep.) |
I. Total operating income | 3,962,074,031.96 | 3,012,251,856.14 |
Including: Operating revenue | 3,962,074,031.96 | 3,012,251,856.14 |
Interest income | ||
Premiums earned | ||
Fee and commission income | ||
II. Total operating costs | 3,246,045,594.62 | 2,570,351,426.19 |
Including: Operating costs | 1,211,286,056.12 | 1,066,572,027.42 |
Interest expenses | ||
Fee and commission expenses | ||
Surrenders | ||
Claims and policyholder benefits (net of amounts recoverable from reinsurers) | ||
Charges in insurance contract reserves (net of reinsurers’ share) | ||
Insurance policyholder dividends | ||
Expenses for reinsurance accepted | ||
Taxes and surcharges | 35,018,710.91 | 26,755,664.49 |
Selling expenses | 1,700,908,422.25 | 1,262,122,598.38 |
General and administrative expenses | 235,718,481.10 | 165,503,097.12 |
Research and development expenses | 95,367,183.34 | 52,455,578.02 |
Financial expenses | -32,253,259.10 | -3,057,539.24 |
Including: Interest expenses | 9,827,780.80 | 7,219,717.71 |
Interest income | 42,468,258.19 | 17,843,073.35 |
Add: Other income | 23,810,575.67 | 12,758,859.43 |
Investment income (Loss is indicated by “-”) | -6,661,294.54 | -5,257,778.42 |
Including: Income from investments in associates and joint ventures | -6,658,316.04 | -5,254,232.18 |
Income from derecognition of financial assets measured at amortized cost | ||
Foreign exchange gains (Loss is indicated by “-”) | ||
Net exposure hedging income (Loss is indicated by “-”) | ||
Income from changes in fair value (Loss is indicated by “-”) | ||
Impairment losses of credit (Loss is indicated by “-”) | 2,180,709.67 | -2,144,694.51 |
Impairment losses of assets (Loss is indicated by “-”) | -113,537,444.60 | -20,365,487.85 |
Income from disposal of assets (Loss is indicated by “-”) | -1,416.28 | |
III. Operating profit (Loss is indicated by “-”) | 621,820,983.54 | 426,889,912.32 |
Add: Non-operating income | 612,654.73 | 144,171.60 |
Less: Non-operating expenses | 916,605.93 | 63,373.82 |
IV. Total profit (Total loss is indicated by “-”) | 621,517,032.34 | 426,970,710.10 |
Less: Income tax expenses | 117,310,409.13 | 79,816,536.07 |
V. Net profit (Net loss is indicated by “-”) | 504,206,623.21 | 347,154,174.03 |
(I) Classified by the nature of continuing operations | ||
1. Net profit from continuing operations (Net loss is indicated by “-”) | 504,206,623.21 | 347,154,174.03 |
2. Net profit from discontinued operations (Net loss is indicated by “-”) | ||
(II) Classified by ownership | ||
1. Net profit attributable to shareholders of the | 495,315,157.18 | 364,296,789.10 |
parent company (Net loss is indicated by “-”) | ||
2. Profit or loss attributable to minority interests (Net loss is indicated by “-”) | 8,891,466.03 | -17,142,615.07 |
VI. Other comprehensive income, net of tax | -364,148.31 | -733,371.78 |
(I) Other comprehensive income attributable to owners of the parent company, net of tax | -364,148.31 | -733,371.78 |
1. Other comprehensive income that cannot be subsequently reclassified to profit or loss | ||
(1) Changes from re-measurement of defined benefit plans | ||
(2) Other comprehensive income that cannot be reclassified to profit or loss under the equity method | ||
(3) Changes in fair value of other investments in equity instruments | ||
(4) Changes in fair value of enterprises’ own credit risks | ||
2. Other comprehensive income that will be reclassified to profit or loss | -364,148.31 | -733,371.78 |
(1) Other comprehensive income that will be reclassified to profit or loss under the equity method | ||
(2) Changes in fair value of other debt investments | ||
(3) Amounts of financial assets reclassified into other comprehensive income | ||
(4) Provision for credit impairment of other debt investments | ||
(5) Reserve for cash flow hedges | ||
(6) Translation differences of financial statements denominated in foreign currencies | -364,148.31 | -733,371.78 |
(7) Others | ||
(II) Other comprehensive income attributable to minority interests, net of tax | ||
VII. Total comprehensive income | 503,842,474.90 | 346,420,802.25 |
(I) Total comprehensive income attributable to owners of the parent company | 494,951,008.87 | 363,563,417.32 |
(II) Total comprehensive income attributable to minority interests | 8,891,466.03 | -17,142,615.07 |
VIII. Earnings per share |
(I) Basic earnings per share (RMB/share) | 1.76 | 1.82 |
(II) Diluted earnings per share (RMB/share) | 1.74 | 1.81 |
In case of business combination under common control, net profit realized by the combined before thecombination in the current period was RMB0.00; net profit realized by the combined in the previousperiod was RMB0.00.
The chairman of the Company: HOU Juncheng | CFO of the Company: WANG Li | Head of Accounting Department: WANG Li |
Consolidated Cash Flow Statement
January to September 2022
Prepared by: Proya Cosmetics Co., Ltd.
Unit: Yuan Currency: RMB Audit Type: Unaudited
Item | First three quarters of 2022 (Jan. to Sep.) | First three quarters of 2021 (Jan. to Sep.) |
I. Cash flows from operating activities: | ||
Cash receipts from the sale of goods and the rendering of services | 4,420,753,595.68 | 3,372,200,521.00 |
Net increase in customer deposits and deposits from banks and other financial institutions | ||
Net increase in loans from the central bank | ||
Net increase in taking from other financial institutions | ||
Cash payments for claims and policyholders’ benefits under direct insurance contracts | ||
Net cash receipts from reinsurance business | ||
Net cash receipts from policyholders’ deposits and investment contract liabilities | ||
Cash receipts from interest, fees and commissions | ||
Net increase in taking from banks and other financial institutions | ||
Net increase in financial assets sold under repurchase arrangements | ||
Net cash received from securities trading agency | ||
Receipts of tax refunds | 5,217,273.91 | 18,501,241.84 |
Other cash receipts relating to operating activities | 94,308,291.64 | 59,335,619.38 |
Sub-total of cash inflows from operating activities | 4,520,279,161.23 | 3,450,037,382.22 |
Cash payments for goods purchased and services received | 1,333,409,994.35 | 1,046,478,917.19 |
Net increase in loans and advances to customers | ||
Net increase in balance with the central bank and due from banks and other financial institution | ||
Cash payments for claims and policyholders’ benefits under direct insurance contracts | ||
Net increase in placements with banks and other financial institutions | ||
Cash payments for interest, fees and commissions | ||
Cash payments for insurance policyholder dividends | ||
Cash payments to and on behalf of employees | 381,128,046.79 | 329,997,403.51 |
Payments of various types of taxes | 398,116,900.07 | 336,370,801.47 |
Other cash payments relating to operating activities | 1,635,750,886.35 | 1,246,701,763.29 |
Sub-total of cash outflows from operating activities | 3,748,405,827.56 | 2,959,548,885.46 |
Net cash flow from operating activities | 771,873,333.67 | 490,488,496.76 |
II. Cash flows from investing activities: | ||
Cash receipts from disposals and recovery of investments | ||
Cash receipts from investment income | ||
Net cash receipts from disposals of fixed assets, intangible assets and other long-term assets | 1,000.00 | |
Net cash receipts from disposals of subsidiaries and other business entities | ||
Other cash receipts relating to investing activities | ||
Sub-total of cash inflows from investing activities | 1,000.00 | |
Cash payments to acquire or construct fixed assets, intangible assets and other long-term assets | 98,040,024.48 | 163,266,984.07 |
Cash payments to acquire investments | 104,185,427.27 | 34,206,800.00 |
Net increase in pledged loans receivables | ||
Net cash payments for acquisitions of subsidiaries and other business units | ||
Other cash payments relating to investing activities | 61,087,857.19 | |
Sub-total of cash outflows from investing activities | 202,225,451.75 | 258,561,641.26 |
Net cash flow from investing activities | -202,225,451.75 | -258,560,641.26 |
III. Cash flows from financing activities: | ||
Cash receipts from capital contributions | 165,676,000.00 | 450,000.00 |
Including: cash receipts from capital contributions from | 700,000.00 | 450,000.00 |
minority owners of subsidiaries | ||
Cash receipts from borrowings | 200,000,000.00 | 200,000,000.00 |
Other cash receipts relating to financing activities | ||
Sub-total of cash inflows from financing activities | 365,676,000.00 | 200,450,000.00 |
Cash repayments of borrowings | 200,000,000.00 | 299,000,000.00 |
Cash payments for distribution of dividends or profits or settlement of interest expenses | 178,569,824.95 | 151,549,422.10 |
Including: payments for distribution of dividends or profits to minority owners of subsidiaries | ||
Other cash payments relating to financing activities | 45,800,000.00 | 1,647,883.50 |
Sub-total of cash outflows from financing activities | 424,369,824.95 | 452,197,305.60 |
Net cash flow from financing activities | -58,693,824.95 | -251,747,305.60 |
IV. Impact of foreign exchange rate changes on cash and cash equivalents | -364,148.31 | -733,371.78 |
V. Net increase in cash and cash equivalents | 510,589,908.66 | -20,552,821.88 |
Add: Opening balance of cash and cash equivalents | 2,378,334,768.09 | 1,401,850,754.88 |
VI. Closing balance of cash and cash equivalents | 2,888,924,676.75 | 1,381,297,933.00 |
The chairman of the Company: HOU Juncheng | CFO of the Company: WANG Li | Head of Accounting Department: WANG Li |
In 2022, the company restates financial statements for the beginning of the year due to theimplementation of new accounting standards or interpretation thereof?Applicable √N/A
Please be notified of above.
Board of Director of Proya Cosmetics Co., Ltd.
October 27, 2022